TraveraRTGx
Completed
72 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
DP-04
Recruiting
100 enrolled
ORI-EGI-03
Recruiting
450 enrolled
MOMENTUM
Recruiting
8,000 enrolled
BASECAMP-1
Recruiting
200 enrolled
iCaRe2
Recruiting
999,999 enrolled
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Recruiting
1,200 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
LOTUS
Recruiting
800 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Recruiting
320 enrolled
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by invitation
1,200 enrolled
DELFI-L101
Completed
2,992 enrolled
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Terminated
19 enrolled
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
PARTNER
Recruiting
6,250 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Recruiting
1,200 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Recruiting
20 enrolled
PREVAILctDNA
Completed
128 enrolled
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Recruiting
20 enrolled
PREFER
Completed
1,429 enrolled
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Recruiting
100 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
TEG
Recruiting
400 enrolled
ROOT
Completed
167 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Recruiting
620 enrolled
Food Reward in Cachexia Induced by Acute or Chronic Disease
Terminated
44 enrolled
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Recruiting
12,000 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Recruiting
5,000 enrolled
ONFM-SBRT
Unknown
57 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Completed
16,506 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Completed
5,133 enrolled
Taiwan Cancer Moonshot Project
Recruiting
4,190 enrolled
PASSION
Unknown
1,800 enrolled
SPACE2
Unknown
150 enrolled
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Terminated
98 enrolled
Nutritional Problems in Pallative Cancer
Completed
44 enrolled
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
Completed
105 enrolled